ECE Professor Elected as OSA Fellow

The Optical Society of America (OSA) has elevated Professor Ji-Xin Cheng (ECE) to the rank of fellow for his outstanding contributions to invention and development of label-free optical spectroscopic imaging technologies with groundbreaking applications to biology, medicine and materials science. A world leader in molecular spectroscopic imaging, Professor Cheng also holds the endowed title of Theodore Moustakas Professor of Optoelectronics and Photonics. He is an AIMBE Fellow and received the Craver Award from Coblentz in 2015.

“This was a perfect reason to come to BU,” says Cheng regarding his recent $3.3M Brain Initiative grant together with Professor Han, “allowing me to collaborate with bright scientists like Xue Han let me quickly build up a new research direction and it made these awards possible.”

OSA Members who have served with distinction in the advancement of optics and photonics may be proposed for election to the class of Fellow. The number of Fellows is limited by the Society’s bylaws to be no more than 10% of the total OSA Membership and the number elected each year is limited to approximately 0.5% of the current membership total.

Professor Cheng and his research team have been at the most forefront of the constantly rising field of molecular spectroscopic imaging in technology, science, and clinical translation. He has authored over 220 peer-reviewed articles with an h-index of 69 (Google Scholar). He organized/chaired 26 national/international symposia and delivered over 200 invited talks. He holds 10 US patents for the invention of the CARS microscope and other technologies and is the lead editor of the first book on coherent Raman scattering microscopy, CRC Press, 2012. In 2014 He co-founded Vibronix Inc which has the mission of saving lives through medical device innovations. Professor Cheng was also recently published in Advances in Engineering and was one of the awardees of a $1.5M Department of Energy grant. Not to mention his recent work in helping to treat breast cancer!